Robert F. Dolski
Senior VP & CFOMr. Robert F. Dolski, also known as Rob, is Chief Financial Officer of Autolus Therapeutics plc from August 7, 2023 and also serves as its Senior Vice President and served as its principal accounting officer since April 03, 2025. He was Principal Accounting Officer of Checkmate Pharmaceuticals, Inc since January 4, 2021. He was Chief Financial Officer of Checkmate Pharmaceuticals, Inc since January 4, 2021. He served as Principal Financial & Accounting Officer at Akcea Therapeutics, Inc since April 2020 until May 2020 and served as its Vice president of Finance since May 2019 until April 2020. He served as Vice President of Finance & Treasurer at Human Genome Sciences Inc. from April 2012 to December 2012. Mr. Dolski joined Human Genome Sciences Inc. in April 2007 as Director of Financial Planning and Analysis. In 2010, he was promoted to Executive Director and in late 2011, assumed responsibility for Treasury functions, including management of Human Genome Sciences Inc. investment accounts, operating cash management and financings. He responsible for Akcea's accounting operations, securities filings reporting, financial planning and treasury activities. Prior to joining Akcea, from June 2016 to May 2019, Mr. Dolski was Vice President of Head of Financial Planning and analysis at Moderna Inc. and from December 2013 to June 2016, Mr. Dolski was Senior Director, Finance at Forum Pharmaceuticals Inc. In addition,from January 2013 to November 2013, Mr. Dolski was an independent finance consultant to multiple healthcare, start-up companies, Mr. Dolski has finance experience in the biotech/pharmaceutical industry. Prior to joining HGS, Mr. Dolski spent seven years at Amgen where he held various Corporate and Operations finance positions, served as Finance Director at Amgen’s largest commercial bulk and fill/finish manufacturing site in Puerto Rico. Mr. Dolski earned an M.B.A from University of Pennsylvania’s Wharton School of Business and a BS in civil engineering and strategic management from the University of Pennsylvania.
Positions
- Company NameAutolus Therapeutics plcStock CodeAUTLPositionSenior VP & CFOColleagues
- CMChristian Martin ItinCEO & Director
- MWMichael Weston BonneyIndependent Chairman of the Board
- MPMartin PuleFounder, Senior VP & Chief Scientific Officer
- CVChristopher VannSenior VP & COO
- PMPatrick McIlvennySenior VP of Finance, Chief Accounting Officer & Principal Accounting Officer
- LCLinda Cathavina BainIndependent Non-Executive Director
- CMCynthia Marie ButittaIndependent Non-Executive Director
- WDWilliam Douglas YoungIndependent Non-Executive Director
